Michigan - AACE 2018 Annual Meeting

Thompsonville, MI US
September 21, 2018 to September 23, 2018

Welcome, and thank you for attending the Michigan-AACE 2018 Annual Meeting.

The Michigan Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

http://syllabus.aace.com/2018/Chapters/Michigan/index.html

Target Audience

Endocrinologists, MD/DOs, advanced practice clinicians, and other healthcare professionals living in or around the state of California who practice, or are interested in, the treatment of endocrine disease states.

Learning Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  2. Attendees will be able to list advantages and disadvantages of new techniques in thyroid surgery
  3. Attendees will be able to interpret intraoperative parathyroid hormone levels and the impact they have on the decision to pursue four gland parathyroid exploration
  4. Attendees will understand considerations for initial and reoperative adrenal surgery.
  5. Attendees will be able to explain pitfalls in localization of functional neuroendocrine tumors as they impact operative intervention
  6. Define "low-risk" thyroid cancer
  7. Understand the benefits and risks of treatment
  8. Tailor treatment to the patient
  9. Recognize clinical signs and of a variety of endocrine disorders
  10. Familiarize yourself with new treatments/technology for a variety of endocrine diseases
  11. Review genetic causes for a variety of endocrine disorders.
  12. Explain the current system in the US for getting medications from the pharmaceutical companies to the patient
  13. Describe which patients are the most vulnerable in not receiving their insulin
  14. Describe the current data for using human insulin instead of insulin analogues in type 2 diabetes
  15. Identify several options for patients who can't afford their insulin
  16. Review basic infrastructure required and principles used for downloading diabetes technology
  17. Review different types of sensor/pump examples for downloading interpretation
  18. Review different current and future platforms for diabetes downloading
  19. To describe an approach to implementation of the new 8th edition AJCC staging system into clinical practice
  20. To describe the ATA risk stratification and response to therapy classification system
  21. To describe how the 8th edition AJCC system and the ATA risk stratification system can be combined to individualize disease specific survival
  22. Understand how to treat giant prolactinomas
  23. Know how to diagnose CSF rhinorrhea
  24. Manage patient with prolactinomas who wish to become pregnant
  25. Discuss the benefits of the Mediterranean and DASH diets
  26. Describe, compare, and contract the DASH diet and Mediterranean diet
  27. List the 9 dietary components of the Mediterranean diet
  28. Describe the health benefits of each fundamental Mediterranean diet component
  29. Quote research-based outcomes used to demonstrate effective diet/health connections
  30. Discuss the clinical implications of novel germ-line mutations in non-syndromic pheochromocytoma
  31. Utilize this case as a basis to consider dopamine agonist dose reduction when managing partially resistant cystic prolactinomas
  32. Understanding different types of Polyglandular Autoimmune syndrome and diagnosis criteria.
  33. Order and interpret laboratory tests for adrenal diseases
  34. Describe the principles of titrating mineralocorticoid antagonist therapy
  35. Execute a directed physical exam to test for hypercortisolism
  36. Individualize the choice of screening tests for a specific patient
  37. Individualize the choice of medical therapy for a specific patient
  38. Modify evaluation of a patient with cyclic hypercortisolism
  39. Attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Nutrition
Obesity
Pituitary
Thyroid
Endo Surgery
Course summary
Available credit: 
  • 11.25 AMA
  • 11.25 Attendance
Course opens: 
09/21/2018
Course expires: 
09/23/2019
Event starts: 
09/21/2018 - 2:30pm
Event ends: 
09/23/2018 - 11:30am
Cost:
$0.00

CRYSTAL MOUNTAIN
12500 CRYSTAL MOUNTAIN DRIVE
THOMPSONVILLE, MI 49683

FRIDAY, SEPTEMBER 21, 2018

2:30 – 3:30 PM

Registration

3:30 – 3:45 PM

Welcome

3:45 – 4:30 PM

What is My Surgeon Doing Now? Hot Topics in Endocrine Surgery
Barbra Miller, MD, FACS
Objectives

  1. Attendees will be able to list advantages and disadvantages of new techniques in thyroid surgery
  2. Attendees will be able to interpret intraoperative parathyroid hormone levels and the impact they have on the decision to pursue four gland parathyroid exploration
  3. Attendees will understand considerations for initial and reoperative adrenal surgery.
  4. Attendees will be able to explain pitfalls in localization of functional neuroendocrine tumors as they impact operative intervention
4:30 – 5:15 PM

Thyroid Cancer: When to treat
Megan Haymart, MD
Objectives

  1. Define "low-risk" thyroid cancer
  2. Understand the benefits and risks of treatment
  3. Tailor treatment to the patient
5:15 – 5:30 PM

Faculty Q & A

5:30 – 6:30 PM

Reception

6:30 – 7:30 PM

Endocrine Trivia Night
Emilie Collins, MD, MS; Kara Hosington 
Objectives

  1. Recognize clinical signs and of a variety of endocrine disorders
  2. Familiarize yourself with new treatments/technology for a variety of endocrine diseases
  3. Review genetic causes for a variety of endocrine disorders.
7:30 – 7:35 PM

Wrap-up / Adjourn

SATURDAY, SEPTEMBER 22, 2018

7:15 – 8:00 AM

Breakfast

8:00 – 8:30 AM

Welcome and Pre-Meeting Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:30 – 9:15 AM

The Real "Enemy of the People": The Cost of Insulin
Irl Hirsch, MD 
Objectives

  1. Explain the current system in the US for getting medications from the pharmaceutical companies to the patient
  2. Describe which patients are the most vulnerable in not receiving their insulin
  3. Describe the current data for using human insulin instead of insulin analogues in type 2 diabetes
  4. Identify several options for patients who can't afford their insulin
9:15 – 10:00 AM

Using and Interpreting Diabetes Data
Irl Hirsch, MD
Objectives

  1. Review basic infrastructure required and principles used for downloading diabetes technology
  2. Review different types of sensor/pump examples for downloading interpretation
  3. Review different current and future platforms for diabetes downloading
10:00 – 10:30 AM

Break

10:30 – 11:15 AM

Risk Stratification in Differentiated Thyroid Cancer 
R. Michael Tuttle, MD
Objectives

  1. To describe an approach to implementation of the new 8th edition AJCC staging system into clinical practice
  2. To describe the ATA risk stratification and response to therapy classification system
  3. To describe how the 8th edition AJCC system and the ATA risk stratification system can be combined to individualize disease specific survival
11:15 – 11:45 PM

Faculty Section Q & A – with all thyroid faculty

11:45 – 12:30 PM

Pituitary Tumors: Unusual situations 
Mark Molitch, MD
Objectives

  1. Understand how to treat giant prolactinomas
  2. Know how to diagnose CSF rhinorrhea
  3. Manage patient with prolactinomas who wish to become pregnant
12:30 – 12:45 PM

Faculty Q & A

12:45 - 2:00 PM

MI AACE Luncheon/meeting

2:00 – 2:45 PM

Culinary Medicine in Clinical Practice 
Tim S. Harlan, MD, FACP, CCMS
Objectives

  1. Discuss the benefits of the Mediterranean and DASH diets
  2. Describe, compare, and contract the DASH diet and Mediterranean diet
  3. List the 9 dietary components of the Mediterranean diet
  4. Describe the health benefits of each fundamental Mediterranean diet component
  5. Quote research-based outcomes used to demonstrate effective diet/health connections
2:45 – 3:00 PM

Faculty Q & A

3:00 – 4:00 PM

Fellows Presentation

3:00 – 3:20 PM

Incidental bilateral adrenal masses with pheochromocytoma and MAX mutation of unknown significance in a hypertensive young man
Asaf Harris, MD
Objectives

  1. Discuss the clinical implications of novel germ-line mutations in non-syndromic pheochromocytoma
3:20 – 3:40 PM

Treating Cystic Prolactinomas with Dopamine Agonists: Partial Cabergoline Resistance and Considering Dose Reduction 
Mohammad Rauf, MD
Objectives

  1. Utilize this case as a basis to consider dopamine agonist dose reduction when managing partially resistant cystic prolactinomas
3:40 – 4:00 PM

Polyglandular Autoimmune Syndrome 
Mingxue Areguello, DO
Objectives

  1. Understanding different types of Polyglandular Autoimmune syndrome and diagnosis criteria.
4:00 PM

Adjourn

7:00 PM

Group Dinner

SUNDAY, SEPTEMBER 23, 2018

7:45 – 8:00 AM

Welcome

8:00 – 8:45 AM

Adrenal Cases 
Richard Auchus, MD, PhD, FACE
Objectives

  1. Order and interpret laboratory tests for adrenal diseases
  2. Describe the principles of titrating mineralocorticoid antagonist therapy
  3. Execute a directed physical exam to test for hypercortisolism
8:45 – 9:30 AM

Update on ACTH-Dependent Cushing's Syndrome 
Lynnette Nieman, MD, FACP
Objectives

  1. Individualize the choice of screening tests for a specific patient
  2. Individualize the choice of medical therapy for a specific patient
  3. Modify evaluation of a patient with cyclic hypercortisolism
9:30 – 9:45 AM

Faculty Section Q & A

9:45 – 10:15 AM

Wrap-up / Post-meeting Assessment
Objectives

  1. Attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities
10:15 – 11:30 AM

Brunch

Crystal Mountain
12500 Crystal Mountain Drive
Thompsonville, MI 49683
United States

Richard Auchus, MD, PhD, FACE
Professor of Internal Medicine/Endocrinology and Pharmacology
Endocrinology Fellowship Program Director
University of Michigan
Ann Arbor, MI

Mingxue Arguello. DO
PGY3 Internal Medicine
Henry Ford Macomb Hospital
Clinton Twp, MI

Emilie Collins, MD, MS
Diabetes and Endocrine Center
Mercy Health Physician Partners, St. Mary's
Grand Rapids, MI

Asaf Harris, MD
PGY-2, Internal Medicine
Michigan State University
Spectrum Health
Grand Rapids, M

Megan Rist Haymart, MD
Associate Professor of Medicine
Division of Metabolism, Endocrinology, and Diabetes and Hematology/Oncology
University of Michigan
Ann Arbor, MI

Timothy Shannon Harlan, MD, FACP, CCMS
Tulane University School of Medicine
Department of Medicine
Section of General Internal Medicine and Geriatrics
New Orleans, LA

Irl B. Hirsch, MD
Professor of Medicine
University of Washington School of Medicine
Seattle, WA

Barbra Miller, MD, FACS
Assistant Professor
Division of Endocrine Surgery
Department of Surgery
Michigan Medicine
University of Michigan
Ann Arbor, MI

Mark Molitch, MD
Martha Leland Sherwin Professor of Endocrinology
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Lynnette Nieman, MD, FACP
Senior Investigator
NIDDK, NIH
Bethesda, MD

Mohammad Talha Rauf, MD
Internal Medicine Resident PGY3
Wayne State University / Detroit Medical Center
Detroit, MI

R. Michael Tuttle, MD
Professor of Medicine
Memorial Sloan-Kettering Cancer Center
New York, NY

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Michigan Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 11.25 AMA
  • 11.25 Attendance

Accreditation Period

Course opens: 
09/21/2018
Course expires: 
09/23/2019

Price

Cost:
$0.00
Please login or register to take this course.